YAP inhibition enhances the differentiation of functional stem cell-derived insulin-producing β cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30931946.
- Also identified by DOI 10.1038/s41467-019-09404-6 and PMC identifier 6443737.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Stem cell-derived insulin-producing beta cells (SC-β) offer an inexhaustible supply of functional β cells for cell replacement therapies and disease modeling for diabetes. While successful directed differentiation protocols for this cell type have been described, the mechanisms controlling its differentiation and function are not fully understood. Here we report that the Hippo pathway controls the proliferation and specification of pancreatic progenitors into the endocrine lineage. Downregulation of YAP, an effector of the pathway, enhances endocrine progenitor differentiation and the generation of SC-β cells with improved insulin secretion. A chemical inhibitor of YAP acts as an inducer of endocrine differentiation and reduces the presence of proliferative progenitor cells. Conversely, sustained activation of YAP results in impaired differentiation, blunted glucose-stimulated insulin secretion, and increased proliferation of SC-β cells. Together these results support a role for YAP in controlling the self-renewal and differentiation balance of pancreatic progenitors and limiting endocrine differentiation in vitro.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Cell Differentiation
- Insulin Secretion
- Insulin-Secreting Cells
- Phosphoproteins
- Pluripotent Stem Cells